Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	DrugBank	薬物名（臨床試験情報から抽出）	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	Interferon beta-1a	32件: Avonex (interferon beta-1a), biogen idec ltd; Bg9418 (interferon beta-1a); Biib017 (peginterferon beta-1a); Device: biib017 (peginterferon beta-1a) autoinjector; Device: biib017 (peginterferon beta-1a) pre-filled syringe (pfs); Device: interferon beta-1a; Human interferon beta-1a and glatiramer acetate; Interferon beta-1a; Interferon beta-1a (avonex); Interferon beta-1a (avonex®); Interferon beta-1a (current approved manufacturing process invloving fbs); Interferon beta-1a (new process, manufactured without fbs); Interferon beta-1a (rebif); Interferon beta-1a (rebif®) alone; Interferon beta-1a 30 µg; Interferon beta-1a fbs-free/hsa free, rnf; Interferon beta-1a fbs-free/hsa-free; Interferon beta-1a fbs-free/hsa-free, rnf; Interferon beta-1a hsa+ biosimilar; Interferon beta-1a hsa-free biosimilar; Interferon beta-1a original; Interferon beta-1a, 30 µg/0.5 ml; New formulation of rebif - human interferon beta-1a; Peginterferon beta-1a; Pegylated interferon beta-1a; Plegridy (peginterferon beta-1a), biogen idec ltd; Rebif (interferon beta-1a); Rebif (interferon beta-1a), merck serono europe ltd; Recombinant human interferon beta-1a; Sc interferon beta-1a; Sc peginterferon beta-1a; Vigantol oil plus interferon beta-1a (rebif);	1件: D04554 💬	2件: IFNAR1, IFNAR2 💬	18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	4件: 13, 26, 96, 97 💬